Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 25;48(8):853-855.
doi: 10.1515/jpm-2020-0128.

Pharmaco-vigilance of oral MethylErgometrine prescriptions for delayed and secondary postpartum haemorrhage

Abdul Rouf Pallivalapila  1 , Isaac A Babarinsa  2   3 , Mariam Al-Baloushi  2 , Ahmed Moursi  1 , Arabo Bayo  2 , Binny Thomas  1 , Mahmoud G Mahmoud Mohd  1
Affiliations

Pharmaco-vigilance of oral MethylErgometrine prescriptions for delayed and secondary postpartum haemorrhage

Abdul Rouf Pallivalapila et al. J Perinat Med. .

Abstract

Objectives The objectives of this study were to quantify the prescription of oral methergin tablets in a busy Women's Hospital, assess the stated indications for such prescription and highlight the issues and safety profile of Methergin use especially in the postpartum patient. Methods Review of prescription data for oral Methergin and the corresponding annual figures on primary and secondary postpartum hemorrhage. Results Over a period of 5 years, oral Methergin prescriptions for delayed and secondary postpartum hemorrhage constituted less than 1% of the overall prescription in Obstetrics and Gynaecology, which ranged between 1214 and 2085 per year. The numbers were too few to ascertain any relationship with both types of postpartum hemorrhage. Although stated on the relevant Patient Information leaflet, no local or regional guideline on its use exist. Conclusions Specific and random trend monitoring of medications for continuing safety profile, risk benefit issues, or unapproved indication, may help in identifying, preventing and mitigating any medication safety matters. Clinical pharmacists in collaboration with physicians are well placed in conducting such pharmacovigilance activities to improve medication safety.

Keywords: oral ergometrine; practice guidelines; secondary postpartum hemorrhage.

PubMed Disclaimer

References

    1. Businaro, R. Why we need efficient and careful pharmacovigilance. J Pharmacovigil 2013;1:e110. https://doi.org/10.4172/2329-6887.1000e110.
    1. Methergin®. In-packet patient information leaflet. Wehr: Novartis. 2012. Reference ID: 3150408. (T2012).
    1. Andersen, B, Andersen, LL, Sorensen, T. Methylergometrine during the early puerperium: a prospective randomized double-blind study. Acta Obstet Gyn Scan 1998;77:54–7. https://doi.org/10.1080/00016349808565812.
    1. de Labriolle, A, Genée, O, Heggs, LM, Fauchier, L. Acute myocardial infarction following oral methyl-ergometrine intake. Cardiovasc Toxicol 2009;9:46–8. https://doi.org/10.1007/s12012-009-9031-9.
    1. Bateman, BT, Huybrechts, KF, Hernandez-Diaz, S, Liu, J, Ecker, JL, Avorn, J. Methylergonovine maleate and the risk of myocardial ischemia and infarction. Am J Obstet Gynecol 2013;209:459.e1–e13. https://doi.org/10.1016/j.ajog.2013.07.001.

MeSH terms

LinkOut - more resources